Horizon Pharma's inflammatory eye drug aces phase 3, poised for midyear BLA - FierceBiotech https://t.co/5Tz39jmHsz
— IDRO (@IDROOhio) March 1, 2019
from Twitter https://twitter.com/IDROOhio
March 01, 2019 at 02:49AM
Friday, March 1, 2019
Horizon Pharma's inflammatory eye drug aces phase 3, poised for midyear BLA - FierceBiotech https://t.co/5Tz39jmHsz
from Twitter https://twitter.com/IDROOhio
March 01, 2019 at 02:49AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment